Tag:
Rheoscience
Latest Headlines
Latest Headlines
Dr. Reddy's spotlights promising Phase III diabetes data
Dr. Reddy's Laboratories says that its first late-stage trial of the experimental diabetes drug balaglitazone hit its primary endpoint for the reduction of blood glucose levels. The
